carmustine has been researched along with Nervous System Diseases in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have compiled the treatment experience of seven neurosurgical centers using implantation of carmustine wafers at primary surgery followed by 6 weeks of radiation therapy (59-60 Gy) and 75 mg/m(2)/day TMZ in patients with newly diagnosed glioblastoma followed by TMZ monochemotherapy." | 3.76 | First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. ( Bock, HC; Buchalla, R; Giese, A; Kantelhardt, SR; Ketter, R; Koll, S; Lohmann, F; Puchner, MJ; Rainov, N; Rohde, V; Schütze, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, T | 1 |
| Nishikawa, R | 1 |
| Sugiyama, K | 1 |
| Nonoguchi, N | 1 |
| Kawabata, N | 1 |
| Mishima, K | 1 |
| Adachi, J | 1 |
| Kurisu, K | 1 |
| Yamasaki, F | 1 |
| Tominaga, T | 1 |
| Kumabe, T | 1 |
| Ueki, K | 1 |
| Higuchi, F | 1 |
| Yamamoto, T | 1 |
| Ishikawa, E | 1 |
| Takeshima, H | 1 |
| Yamashita, S | 1 |
| Arita, K | 1 |
| Hirano, H | 1 |
| Yamada, S | 1 |
| Matsutani, M | 1 |
| Bock, HC | 1 |
| Puchner, MJ | 1 |
| Lohmann, F | 1 |
| Schütze, M | 1 |
| Koll, S | 1 |
| Ketter, R | 1 |
| Buchalla, R | 1 |
| Rainov, N | 1 |
| Kantelhardt, SR | 1 |
| Rohde, V | 1 |
| Giese, A | 1 |
| Herman, TS | 1 |
| Zukoski, CF | 1 |
| Anderson, RM | 1 |
| Hutter, JJ | 1 |
| Blitt, CD | 1 |
| Malone, JM | 1 |
| Larson, DF | 1 |
| Dean, JC | 1 |
| Roth, HB | 1 |
| Papadakis, V | 1 |
| Dunkel, IJ | 1 |
| Cramer, LD | 1 |
| Kramer, E | 1 |
| Papadopoulos, E | 1 |
| Goldman, S | 1 |
| Packer, RJ | 1 |
| Willoughby, M | 1 |
| Baker, D | 1 |
| Garvin, J | 1 |
| Strandjord, S | 1 |
| Coccia, P | 1 |
| Kaplan, AM | 1 |
| Klemperer, M | 1 |
| Finlay, JL | 1 |
| Rogers, LR | 1 |
| Purvis, JB | 1 |
| Lederman, RJ | 1 |
| Rosenbloom, SA | 1 |
| Tomsak, RL | 1 |
| Estes, ML | 1 |
| Magdinec, M | 1 |
| Medendorp, SV | 1 |
| Boyett, JM | 1 |
| Desser, RK | 1 |
| Ultmann, JE | 1 |
1 review available for carmustine and Nervous System Diseases
| Article | Year |
|---|---|
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmu | 1973 |
2 trials available for carmustine and Nervous System Diseases
| Article | Year |
|---|---|
A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Combined Modality Thera | 2014 |
Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modalit | 1991 |
3 other studies available for carmustine and Nervous System Diseases
| Article | Year |
|---|---|
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Combined Modality Thera | 2010 |
Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies.
Topics: Adult; Antineoplastic Agents; Burns; Carmustine; Child; Cisplatin; Evaluation Studies as Topic; Fema | 1982 |
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 2000 |